Review articlePublished 2013
A Region-specific Treatment Strategy To Address The Problem Of Drug Resistance By NDM-1-producing Pathogens
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
New Delhi metallo-β-lactamase (NDM-1) is a serious threat to the existing antibiotic armory, and a potent weapon for bacteria to aid in in their ‘battle’. It has the ability to inactivate all β-lactams, except aztreonam. However, most of the NDM-1-producers also produce aztreonam hydrolysing-β-lactamases, thereby making these pathogens absolutely resistant to all β-lactams. This minireview incorporates a concise update on global epidemiology (2009- 2012) of NDM-1. However, the crux of the discussion is to focus on paucity of clinically useful therapeutic options, and suggest a solution to the drug resistance threat imposed by NDM-1 bacterial enzyme. The manuscript presents a ‘region-specific treatment strategy’ in a lucid flowchart format. The flowchart which lies at the interface of clinical microbiology and bioinformatics is expected to be useful in containing the problem of drug resistance due to NDM- 1-producing bacterial pathogens.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalEnzyme Engineering
- SubjectBiochemistry & Biotechnology
- SubjectEngineering
- BylineArticles whose byline prints “Shazi Shakil”
- BylineArticles whose byline prints “Adnan Ahmad”
- BylineArticles whose byline prints “Shams Tabrez”
- BylineArticles whose byline prints “Ghulam M. Ashraf”
- BylineArticles whose byline prints “Aftab A.P. Khan”
- BylineArticles whose byline prints “Adel M. Abuzenadah”
- BylineArticles whose byline prints “Mohammad A. Kamal”
